quinazolines has been researched along with thromboxane b2 in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (50.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Chaffoy de Courcelles, D; De Clerck, F; Kennis, L; Roevens, P; Somers, Y; Van Belle, H | 1 |
| Ball, J; Greaves, M; Jackson, C; Lawry, J; Peel, J; Preston, FE | 1 |
| Huttemeier, PC; Melvin, C; Morel, DR; Nguyenduy, T; Robinson, DR; Skoskiewicz, MJ; Zapol, WM | 1 |
| Isomäki, H; Laitinen, O; Nissilä, M; Nuotio, P; Nykänen, E; Seppälä, E; Vapaatalo, H | 1 |
| Baruth, H; Crowley, HJ; Hope, WC; Miller, DA; O'Donnell, M; Welton, AF; Yaremko, B | 1 |
| Barrett, PA; Butler, KD | 1 |
| Chern, JW; Chou, TC; Ding, YA; Yen, MH | 1 |
| Hung, WC; Lee, YM; Sheu, JR; Yen, MH | 1 |
| Kornblihtt, LI; Laguna, MS; Marta, RF; Molinas, FC | 1 |
| Kanazawa, S; Kinoshita, Y; Komiyama, Y; Muramatsu, M; Nomura, S; Yamaguchi, K | 1 |
| Hanayama, K; Hirashima, T; Imamura, F; Kanazawa, S; Kinoshita, Y; Nomura, S; Sasada, S; Siomi, K; Tujimoto, M; Yamaguchi, K | 1 |
| Guo, RL; He, KW; Hu, YY | 1 |
1 trial(s) available for quinazolines and thromboxane b2
| Article | Year |
|---|---|
Aspirin reduces adverse effects of gefitinib.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Carcinoma, Non-Small-Cell Lung; Drug Interactions; Female; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Quinazolines; Thromboxane B2 | 2006 |
11 other study(ies) available for quinazolines and thromboxane b2
| Article | Year |
|---|---|
The role of endogenously formed diacylglycerol in the propagation and termination of platelet activation. A biochemical and functional analysis using the novel diacylglycerol kinase inhibitor, R 59 949.
Topics: Blood Platelets; Calcium; Cell Membrane; Collagen; Cyclic AMP; Diacylglycerol Kinase; Diglycerides; Glycerides; Humans; Phosphates; Phosphatidylinositols; Phospholipids; Phosphoproteins; Phosphorylation; Phosphotransferases; Piperidines; Platelet Aggregation; Protein Kinase C; Quinazolines; Quinazolinones; Second Messenger Systems; Thromboxane B2; Vasopressins | 1989 |
DN 9693: a phosphodiesterase inhibitor with a platelet membrane effect.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine Triphosphate; Antibodies, Monoclonal; Cyclic AMP; Humans; In Vitro Techniques; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Quinazolines; Ristocetin; Serotonin; Thromboxane B2 | 1989 |
Dose-dependent effects of a pyridoquinazoline thromboxane synthetase inhibitor on arachidonic acid metabolites and hemodynamics during E. coli endotoxemia in anesthetized sheep.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Dinoprostone; Endotoxins; Escherichia coli; Hemodynamics; Kinetics; Lymph; Prostaglandins E; Prostaglandins F; Pulmonary Artery; Quinazolines; Sheep; Thromboxane B2; Thromboxane-A Synthase; Toxemia; Vascular Resistance | 1987 |
Comparison of the effects of different anti-inflammatory drugs on synovial fluid prostanoid concentrations in patients with rheumatoid arthritis.
Topics: 6-Ketoprostaglandin F1 alpha; Acetaminophen; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Carbazoles; Diclofenac; Dinoprostone; Guanidines; Humans; Indomethacin; Naproxen; ortho-Aminobenzoates; Prednisolone; Prostaglandins; Prostaglandins E; Quinazolines; Synovial Fluid; Thromboxane B2 | 1985 |
Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
Topics: Aerosols; Anaphylaxis; Animals; Cromolyn Sodium; Drug Evaluation, Preclinical; Guinea Pigs; Histamine Release; Hypersensitivity, Immediate; Ileum; In Vitro Techniques; Lung; Male; Passive Cutaneous Anaphylaxis; Quinazolines; Rats; Rats, Inbred Strains; SRS-A; Thromboxane B2 | 1984 |
Shortening of platelet survival by induced hypercholesterolaemia in rabbits and its prolongation by anagrelide.
Topics: Animals; Arteriosclerosis; Blood Platelets; Cell Survival; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Diet, Atherogenic; Female; Half-Life; Hypercholesterolemia; Lipoproteins, HDL; Male; Platelet Aggregation; Quinazolines; Rabbits; Thromboxane B2; Triglycerides | 1983 |
Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Arachidonic Acid; Blood Platelets; Calcium; Collagen; Cyclic AMP; Epinephrine; Fibrinogen; Humans; Imidazoles; Pancreatic Elastase; Phosphatidylinositols; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Quinazolines; Rabbits; Receptors, Cell Surface; Signal Transduction; Thromboxane A2; Thromboxane B2 | 1995 |
Mechanism of inhibition of platelet aggregation by rutaecarpine, an alkaloid isolated from Evodia rutaecarpa.
Topics: Alkaloids; Blood Platelets; Cyclic AMP; Cyclic GMP; Humans; Indole Alkaloids; Nitric Oxide; Phosphatidylinositols; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinazolines; Thromboxane B2 | 1996 |
[Thromboxane B2 and platelet derived growth factor in essential thrombocythemia treated with anagrelide].
Topics: Adult; Aged; Female; Fibrinolytic Agents; Humans; Immunoenzyme Techniques; Male; Middle Aged; Platelet Count; Platelet-Derived Growth Factor; Quinazolines; Thrombocythemia, Essential; Thromboxane B2 | 2000 |
Effect of low-dose aspirin for skin rash associated with erlotinib therapy in patients with lung cancer.
Topics: Aged; Aspirin; Dose-Response Relationship, Drug; Erlotinib Hydrochloride; Exanthema; Female; Humans; Lung Neoplasms; Male; Platelet Activation; Platelet Aggregation Inhibitors; Protein Kinase Inhibitors; Quinazolines; Thromboxane B2; Treatment Outcome | 2009 |
Six alkaloids inhibit secretion of IL-1α, TXB(2), ET-1 and E-selectin in LPS-induced endothelial cells.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Benzylisoquinolines; Cells, Cultured; Down-Regulation; Drugs, Chinese Herbal; E-Selectin; Endothelin-1; Endothelium, Vascular; Evodia; Humans; Interleukin-1alpha; Lipopolysaccharides; Morphinans; Proline; Pyrazines; Quinazolines; Quinolizines; Swine; Thromboxane B2 | 2012 |